SCHEMBL12307524

SCHEMBL12307524

CNC(=O)Nc1cc2n(n1)CCN2c1cccc(OCc2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ TSHR P16473 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GRM5 P41594 1/20 0.41
▸ FAAH O00519 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ F10 P00742 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12307484 0.85 KMT2A (0.40) ALDH1A1KMT2AGAAHTTLMNA
SCHEMBL12307576 0.84 ITGB3 (0.38) ALDH1A1MAPTUSP2KMT2AHPGD
SCHEMBL12307530 0.82 MEN1 (0.34) ALDH1A1MAPTKMT2AGAASMN1; SMN2
SCHEMBL12307489 0.81 KMT2A (0.39) ALDH1A1MAPTKMT2AGAASMN1; SMN2
SCHEMBL12307703 0.81 ADORA2A (0.46) ALDH1A1MAPTSMN1; SMN2GRM5FAAH
SCHEMBL12307511 0.81 ALDH1A1 (0.43) ALDH1A1TSHRMAPTUSP2KMT2A
SCHEMBL12533017 0.80 KCNQ2 (0.33) —
SCHEMBL12307596 0.79 MAPK13 (0.38) MAPTKMT2ASMN1; SMN2LMNAGCK
SCHEMBL12307574 0.79 RIPK1 (0.35) ALDH1A1KMT2AGAALMNASLC5A1
SCHEMBL12307586 0.79 KMT2A (0.40) ALDH1A1TSHRMAPTKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed
EP-2327704-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY Shionogi&Co., Ltd. (JP) 2011-06-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY PIK3R5, PIK3R4, PIK3R1 ALDH1A1 3559/4885TSHR 3682/4885MAPT 4347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback